KLRC1 and acute myeloid leukemia: As previously reported, most NK cells in AML patients in remission expressed NKG2A.16 However, NKG2A GG patients still harbored a higher percentage of NKG2A+KIR+/- cells when compared with C/x patients (figure 3I).